Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
373
datasets available to search
ShareScore release 0.9.0
Dataset results
373 results for “Chronic myeloid leukemia”
Bosutinib in Pediatric Patients With Newly Diagnosed Chronic Phase or Resistant/Intolerant Ph + Chronic Myeloid Leukemia
ClinicalTrials.gov study NCT04258943. IPD Sharing: Not stated. Countries: 8. Publications: 2.
Interventional Study to Improve Adherence to Tyrosine Kinase Inhibitors in Chronic Myeloid Leukemia
ClinicalTrials.gov study NCT01768689. IPD Sharing: NO. Countries: 1. Publications: 7.
Effects of a Digital Patient Platform (CMyLife) for Patients With Chronic Myeloid Leukemia (CML) on Information Provision, Patient Empowerment, Medication Compliance, Guideline Adherence and Quality o
ClinicalTrials.gov study NCT04595955. IPD Sharing: UNDECIDED. Countries: 1. Publications: 1.
Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting
ClinicalTrials.gov study NCT01244750. IPD Sharing: Not stated. Countries: 8. Publications: 1.
A Pivotal Study of HQP1351 in Patients of Chronic Myeloid Leukemia in Accelerated Phase With T315I Mutation
ClinicalTrials.gov study NCT03883100. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Expanded Access Program of AMN107 in Imatinib-resistant or Intolerant Adult Patients With Chronic Myeloid Leukemia
ClinicalTrials.gov study NCT00302016. IPD Sharing: Not stated. Countries: 34. Publications: 1.
Safety and Efficacy of Pegylated IFN-alpha 2B Added to Dasatinib in Newly Diagnosed Chronic Phase Myeloid Leukemia
ClinicalTrials.gov study NCT01725204. IPD Sharing: Not stated. Countries: 3. Publications: 2.
Pharmacogenomics Validation for Imatinib in Chronic Myeloid Leukemia
ClinicalTrials.gov study NCT01437202. IPD Sharing: Not stated. Countries: 2. Publications: 7.
Low-dose Dasatinib as First-line Treatment for Chronic Myeloid Leukemia
ClinicalTrials.gov study NCT03216070. IPD Sharing: NO. Countries: 1. Publications: 5.
Tanespimycin and Cytarabine in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Chronic Myelogenous Leukemia, Chronic Myelomonocytic Leukemia, or Mye
ClinicalTrials.gov study NCT00098423. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Flavopiridol in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, or Chronic Myelogenous Leukemia
ClinicalTrials.gov study NCT00101231. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Impact of a Pharmaceutical Care Model in the Management of Chronic Myeloid Leukemia Patients
ClinicalTrials.gov study NCT03090477. IPD Sharing: NO. Countries: 1. Publications: 6.
Imatinib Discontinuation in Patients With Chronic Myeloid Leukemia Chronic Phase With Sustained MR4log
ClinicalTrials.gov study NCT03239886. IPD Sharing: NO. Countries: 1. Publications: 1.
Dynamic Changes in the Levels of sCD62L and SPARC in Chronic Myeloid Leukemia Patients During Imatinib Treatment
ClinicalTrials.gov study NCT05387330. IPD Sharing: UNDECIDED. Countries: 1. Publications: 4.
Data from: A novel Imatinib analog inhibitor of chronic myeloid leukemia: design, synthesis, and characterization. Explanation of its folded conformation
Open the record for dataset details and reuse information.
Coexisting of hearing loss and chronic myeloid leukemia: A systematic literature review
Open the record for dataset details and reuse information.
Dasatinib for imatinib-resistant/intolerant patients with chronic phase chronic myeloid leukemia_database INFINITY_data_export
Open the record for dataset details and reuse information.
Article data of The Impact of MDR-1 Gene Polymorphism (rs1128503) on Response to Imatinib and nilotinib Treatment in A Sample of Iraqi Chronic Myeloid Leukemia-Chronic Phase Patients
Open the record for dataset details and reuse information.
Article data of The Impact of MDR-1 Gene Polymorphism (rs1128503) on Response to Imatinib and nilotinib Treatment in A Sample of Iraqi Chronic Myeloid Leukemia-Chronic Phase Patients
Open the record for dataset details and reuse information.
An Extension Study to Determine the Efficacy and Safety of STI571 in Participants With Chronic Myeloid Leukemia Who Are Refractory to or Intolerant of Interferon-Alpha
ClinicalTrials.gov study NCT00171223. IPD Sharing: Not stated. Countries: 6. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.